Verici Dx PLC (AIM:VRCI) shares skipped 12% higher to 0.7p after the developer of diagnostic tests for organ transplants bagged a new agreement with a healthcare network in the United States.
The deal with Prime Health Services sees Verici Dx join a preferred provider network, giving its services access to more than 850,000 healthcare providers and 35 million insurance claims a year.
Such networks negotiate standard pricing with insurers, helping to cut costs and reduce billing disputes.
Chief operating officer Patti Connolly said the deal was “an important milestone” that would “expand our patient network and support our approach to increased coverage from private payors.”